As a point-of-care test, we expect that the FDA’s Emergency Use Authorization will allow the test to only be administered by organizations that are either certified or waived under the CLIA (Clinical Laboratory Improvement Amendments) regulations which are enforced by the federal government, specifically the Centers for Medicare and Medicaid Services (CMS). The Inspire Community Health Testing Program will be administered by technicians with the required state and federal certifications.